Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Chief Operating Officer | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CASTLE BIOSCIENCES INC
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,356 |
Ending reported balance
After 2026-10-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 4,153 · Balance 17,509 F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. Row 2 · 2026-10-01 · Sale · Disposed 2,807 · Balance 14,702 F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F2: This transaction was executed in multiple trades at prices ranging from $35.21 to $36.19, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2026-10-01 · Sale · Disposed 1,346 · Balance 13,356 F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F3: This transaction was executed in multiple trades at prices ranging from $36.21 to $36.78, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.38 · Expires 2029-03-12 | Direct | 8,305 |
Reported balance
After 2026-10-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-01 · Exercise / conversion · Disposed 4,153 · Balance 8,305 F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F5: The shares subject to the option are fully vested. |
| Common StockSEC Table I · non-derivative | IndirectThe Fritz Shorter Trust | 72,649 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 72,649 F4: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries. |
Filing footnotes · ownership attribution and instrument terms
F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.
F2: This transaction was executed in multiple trades at prices ranging from $35.21 to $36.19, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $36.21 to $36.78, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.
F5: The shares subject to the option are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 4,153 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · derivative · entry 5 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,305 Underlying: Common Stock · 4,153 shares Expires 2029-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F5 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 1,346 | $36.38 | $48,967.48 |
DisclosureSEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · nonDerivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,356 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $36.21 to $36.78, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,807 | $35.75 | $100,350.25 |
DisclosureSEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,702 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.21 to $36.19, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 4,153 | $3.38 | $14,037.14 |
DisclosureSEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 4,152 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · derivative · entry 5 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,458 Underlying: Common Stock · 4,152 shares Expires 2029-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F5 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 200 | $34.02 | $6,804.00 |
DisclosureSEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · nonDerivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,356 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,952 | $33.36 | $131,838.72 |
DisclosureSEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,556 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.015 to $33.900, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 4,152 | $3.38 | $14,033.76 |
DisclosureSEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F2 · balance_after: Includes 68 shares acquired on August 31, 2026, under the Issuer's employee stock purchase plan. Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 20:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 5,223 | $34.64 | $180,919.50 |
DisclosureSEC source: 0001628280-26-059091 · wk-form4_1787775408.xml · nonDerivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · The Fritz Shorter Trust Disclosed balance after: 72,649 F4 · price: This transaction was executed in multiple trades at prices ranging from $34.495 to $34.750, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries. Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 20:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 7,161 | $34.26 | $245,357.34 |
DisclosureSEC source: 0001628280-26-059091 · wk-form4_1787775408.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · The Fritz Shorter Trust Disclosed balance after: 77,872 F3 · price: This transaction was executed in multiple trades at prices ranging from $33.470 to $34.460, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 20:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 12,218 | $33.69 | $411,587.77 |
DisclosureSEC source: 0001628280-26-059091 · wk-form4_1787775408.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · The Fritz Shorter Trust Disclosed balance after: 85,033 F1 · price: This transaction was executed in multiple trades at prices ranging from $33.500 to $33.885, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 1,100 | $30.62 | $33,682.00 |
DisclosureSEC source: 0001628280-26-053391 · wk-form4_1785961098.xml · nonDerivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,288 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F4 · price: This transaction was executed in multiple trades at prices ranging from $30.55 to $30.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 4,486 | $30.00 | $134,580.00 |
DisclosureSEC source: 0001628280-26-053391 · wk-form4_1785961098.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,388 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $29.53 to $30.44, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,000 | $29.12 | $87,360.00 |
DisclosureSEC source: 0001628280-26-053391 · wk-form4_1785961098.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,874 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $28.46 to $29.45, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:24 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 400 | $24.78 | $9,912.00 |
DisclosureSEC source: 0001628280-26-047286 · wk-form4_1783369493.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,874 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.77 to $24.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:24 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 8,186 | $24.40 | $199,738.40 |
DisclosureSEC source: 0001628280-26-047286 · wk-form4_1783369493.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,274 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.73 to $24.72, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:19 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 8,587 | $20.71 | $177,836.77 |
DisclosureSEC source: 0001628280-26-044327 · wk-form4_1781813983.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,460 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.51 to $20.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 11,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · derivative · entry 7 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,878 Underlying: Common Stock · 11,960 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: On March 4, 2025, the Reporting Person was granted 47,838 RSUs which vest in four equal installments beginning on March 4, 2026. F7 · derivative.expiration_date: On March 4, 2025, the Reporting Person was granted 47,838 RSUs which vest in four equal installments beginning on March 4, 2026. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 13,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · derivative · entry 6 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,621 Underlying: Common Stock · 13,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025. F6 · derivative.expiration_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 6,792 | $28.17 | $191,330.64 |
DisclosureSEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · nonDerivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,047 Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 25,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 48,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · derivative · entry 5 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,367 Underlying: Common Stock · 48,367 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 03, 2027. F5 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 03, 2027. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 2,427 | $27.57 | $66,912.39 |
DisclosureSEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,068 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the delivery of vested performance stock units reported on January 12, 2026. F2 · balance_after: Includes 965 shares acquired on February 27, 2026, under the Issuer's employee stock purchase plan. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:30 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantPerformance-Based Stock Unit · Derivative | 9,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001856565-26-000002 · form4-01142026_040106.xml · derivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,207 Underlying: Common Stock · 9,207 shares Expires not disclosed F3 · derivative.exercise_price: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2024 PSUs which will vest subject to the achievement of certain milestones. F3 · derivative.exercise_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2024 PSUs which will vest subject to the achievement of certain milestones. F3 · derivative.expiration_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2024 PSUs which will vest subject to the achievement of certain milestones. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:30 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantCommon Stock | 9,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001856565-26-000002 · form4-01142026_040106.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,530 F1 · shares: Represents 50% of the Performance-Based Stock Units ("PSUs") granted on March 4, 2024 ("2024 PSUs") that vested based on the satisfaction of certain performance criteria as certified by the board of directors of the Issuer on January 12, 2026. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 14,888 | $39.31 | $585,291.94 |
DisclosureSEC source: 0001628280-25-058246 · wk-form4_1766178376.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,323 F1 · price: This transaction was executed in multiple trades at prices ranging from $39.055 to 39.830, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:47 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 6,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · derivative · entry 7 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022. F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:47 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 2,552 | $38.02 | $97,027.04 |
DisclosureSEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 4 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,211 Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:47 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 6,170 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 23:47 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 15,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · derivative · entry 6 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,961 Underlying: Common Stock · 15,961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023. F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 23:47 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 4,691 | $38.25 | $179,430.75 |
DisclosureSEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,593 Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 23:47 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 15,961 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 18,932 | $35.10 | $664,513.20 |
DisclosureSEC source: 0001628280-25-052013 · wk-form4_1763068055.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,323 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 6, 2025 F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.37, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: On November 11, 2025, the Reporting Person transferred 3,686 shares from the Fritz Shorter Trust to their direct holdings. Read SEC document |
| October 31, 2025 Filed Nov 5, 2025 01:56 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 12,678 | $25.04 | $317,457.12 |
DisclosureSEC source: 0001628280-25-049189 · wk-form4_1762307784.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,569 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 6, 2025 F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to 25.12, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 12,677 | $22.02 | $279,134.86 |
DisclosureSEC source: 0001856565-25-000007 · wk-form4_1756497883.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,116 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 6, 2025 F2 · price: This transaction was executed in multiple trades at prices ranging from $22.000 to 22.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 18,007 | $21.69 | $390,571.83 |
DisclosureSEC source: 0001856565-25-000006 · wk-form4_1756497844.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,793 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.24 to $21.94, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 27, 2025 Filed Nov 5, 2025 01:38 UTC Amendment | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 18,007 | $21.69 | $390,571.83 |
DisclosureSEC source: 0001628280-25-049176 · wk-form4a_1762306678.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · The Fritz Shorter Trust Disclosed balance after: 100,937 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.24 to $21.94, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: On August 29, 2025, the Reporting Person filed a Form 4 which inadvertently reported that shares were sold by the Reporting Person directly. In fact, as reported in this amendment, the shares were sold by the Fritz Shorter Trust (the "Trust"). The original Form 4 also mistakenly indicated the wrong number of shares held by the Reporting Person directly and indirectly through the Trust. In fact, following this sale, the Reporting Person held 52,924 shares of common stock directly and 100,937 shares of common stock indirectly through the Trust. In addition, following a reconciliation of the reporting person's holdings, it was determined that the balance previously reported was understated by 68 shares, and the holdings reported herein have been adjusted accordingly. F3 · ownership.nature: On March 19, 2025 and on August 22, 2025, the Reporting Person transferred 96,322 and 22,622 shares to the Trust. The transfer was not a change in beneficial ownership because the Reporting Person and her spouse are the trustees and sole beneficiaries of the Trust, the Trust is revocable and the Reporting Person has voting and investment power over the shares held by the Trust. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:31 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionPerformance-Based Stock Unit · Derivative | 10,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001856565-25-000003 · wk-form4_1755030668.xml · derivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024. F1 · derivative.exercise_date: Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024. F1 · derivative.expiration_date: Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:31 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 2,804 | $19.36 | $54,285.44 |
DisclosureSEC source: 0001856565-25-000003 · wk-form4_1755030668.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,800 Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:31 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 10,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001856565-25-000003 · wk-form4_1755030668.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:19 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 13,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · derivative · entry 4 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,432 Underlying: Common Stock · 13,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025. F4 · derivative.expiration_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:19 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 47,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · derivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,838 Underlying: Common Stock · 47,838 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2026. F3 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2026. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:19 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 3,640 | $22.23 | $80,917.20 |
DisclosureSEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · nonDerivative · entry 2 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,964 Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:19 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 13,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · nonDerivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 1,271 shares acquired on February 28, 2025, under the Issuer's employee stock purchase plan. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:49 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 6,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · derivative · entry 9 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,170 Underlying: Common Stock · 6,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022. F5 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:49 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · derivative · entry 8 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021. F4 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:49 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 1,626 | $29.63 | $48,178.38 |
DisclosureSEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 6 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,522 Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:49 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 6,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 5 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:49 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 530 | $29.63 | $15,703.90 |
DisclosureSEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 4 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,979 Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:49 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 3 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.